Baseline Characteristics
| Parameter | Patients (n = 80) |
| Age (median years [IQR]) | 65.5 (56.8–73.3) |
| Female (n [%]) | 27 (34) |
| Average BMI (kg/m2 [IQR]) | 28.6 (25.4–35.6) |
| Service (n [%]) | |
| Orthopedic | 13 (16) |
| Neurosurgery | 13 (16) |
| General surgery | 20 (25) |
| ICU | 34 (43) |
| Dialysis (n [%]) | 3 (4) |
| Parenteral nutrition (n [%]) | 10 (13) |
| Enteral nutrition (n [%]) | 10 (13) |
| Systemic corticosteroids (n [%]) | 28 (35) |
| Parenteral or enteral nutrition or systemic corticosteroids (n [%]) | 42 (53) |
| Baseline serum glucose (mean mg/dL [SD]) | 208 (46) |
| IQR, interquartile range |
| Parameter | Patients (n = 80) |
| Age (median years [IQR]) | 65.5 (56.8–73.3) |
| Female (n [%]) | 27 (34) |
| Average BMI (kg/m2 [IQR]) | 28.6 (25.4–35.6) |
| Service (n [%]) | |
| Orthopedic | 13 (16) |
| Neurosurgery | 13 (16) |
| General surgery | 20 (25) |
| ICU | 34 (43) |
| Dialysis (n [%]) | 3 (4) |
| Parenteral nutrition (n [%]) | 10 (13) |
| Enteral nutrition (n [%]) | 10 (13) |
| Systemic corticosteroids (n [%]) | 28 (35) |
| Parenteral or enteral nutrition or systemic corticosteroids (n [%]) | 42 (53) |
| Baseline serum glucose (mean mg/dL [SD]) | 208 (46) |
| IQR, interquartile range |